EUVIMEDOdkrijte EUVIMED
Crossref

Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy

S Yamasaki, N Kan, K Mise, T Harada, Y Ichinose, Y Moriguchi, H Kodama, K Satoh, K Ohgaki, T Tobe

Biotherapy · 1993

DOI: 10.1007/bf01877387 ↗

At a glance

Journal article in Biotherapy, 1993. Written by S Yamasaki and 9 co-authors. Institution: First Department of Surgery, Faculty of Medicine, Kyoto University, Japan. Cited 4 times so far (Crossref); 19 references.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

In patients with Stage II or III breast cancer and in patients with liver metastases from breast cancer, we examined cellular interaction in the cytotoxicity against autologous tumor cells by interleukin-2(IL-2)-cultured lymphocytes (CL) and fresh peripheral blood lymphocytes (FPBL) treated with immunochemotherapy including OK-432 and cyclophosphamide. In flow cytometric analysis, CD8+CD11b+ and CD16+ cells significantly decreased after immuno-chemotherapy in both groups of patients. A protocol study in Stage II or III breast cancer patients showed suppressive activity of FPBL on the cytotoxic activity of CL in 3/9 of the non-treatment group but no suppressive activity and enhancing activity in 3/7 in the immuno-chemotherapy group. Moreover, in 19 patients with liver metastases from breast cancer treated with immuno-chemotherapy including adoptive immunotherapy, FPBL in 6/19 showed enhancing activity, and in 8/19 suppressive activity in the lysis of autologous tumor cells. In assays in vitro using autologous and allogeneic tumor cells, FPBL showed a partial specificity in cellular interaction against autologous tumor cells. CD4-depleted FPBL inhibited cytotoxicity of CL, while CD8-depleted FPBL enhanced cytotoxicity of CL in patients with liver metastases. These results suggest that immuno-chemotherapy eliminates the suppressive population in FPBL and may induce tumor regression if combined with adoptive immunotherapy using CL.

Subjects

MeSH terms (MEDLINE)

Adjuvants, ImmunologicAdultAgedAntigens, SurfaceBreast NeoplasmsCombined Modality TherapyCytotoxicity, ImmunologicFemaleHumansImmunotherapy, AdoptiveInterleukin-2Liver NeoplasmsLymphocyte TransfusionLymphocytesMiddle AgedNeoplasm StagingPhenotypePostoperative PeriodTumor Cells, Cultured

Substances

Adjuvants, ImmunologicAntigens, SurfaceInterleukin-2

Authors and institutions

  • First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

Cite

APA

Yamasaki, S., Kan, N., Mise, K., Harada, T., Ichinose, Y., Moriguchi, Y., Kodama, H., Satoh, K., Ohgaki, K., & Tobe, T. (1993). Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy. Biotherapy. https://doi.org/10.1007/bf01877387

Vancouver

Yamasaki S, Kan N, Mise K, Harada T, Ichinose Y, Moriguchi Y, et al. Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy. Biotherapy. 1993. doi:10.1007/bf01877387

BibTeX
@article{Yamasaki1993,
  author = {Yamasaki, S and Kan, N and Mise, K and Harada, T and Ichinose, Y and Moriguchi, Y and Kodama, H and Satoh, K and Ohgaki, K and Tobe, T},
  title = {Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy},
  journal = {Biotherapy},
  year = {1993},
  doi = {10.1007/bf01877387}
}
Start for free →